AerWave announced today that it completed the first-in-human feasibility study of its disease-modifying ultrasound lung denervation therapy. New York-based AerWave also raised $12 million to further advance its therapy for chronic obstructive pulmonary disease (COPD) and asthma. The ultrasound platform aims to simplify and enhance lung … [Read more...] about AerWave completes first-in-human study of lung denervation tech
